Literature DB >> 22975752

You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need.

Kevin L Winthrop, Michael E Weinblatt, Charles L Daley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22975752     DOI： 10.1136/annrheumdis-2012-201979

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

Review 1.  Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.

Authors:  Kevin L Winthrop; Michael Iseman
Journal:  Nat Rev Rheumatol       Date:  2013-06-25       Impact factor: 20.543

2.  [Are the recommendations on tuberculosis screening still valid? Interferon gamma release assay (IGRA) and/or tuberculin skin test for diagnosis of latent tuberculosis infection (LTBI)].

Authors:  D Ernst; T Witte; R E Schmidt; D Meyer-Olson
Journal:  Z Rheumatol       Date:  2013-11       Impact factor: 1.372

3.  Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay.

Authors:  S A R Siegel; M Cavanaugh; J H Ku; L M Kawamura; K L Winthrop
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

4.  Diagnosis of latent tuberculosis infection with T-SPOT(®).TB in a predominantly immigrant population with rheumatologic disorders.

Authors:  Patricio Escalante; Kirstin J Kooda; Rizwana Khan; San San Aye; Stratos Christianakis; Daniel G Arkfeld; Glenn R Ehresmann; Jens J Kort; Brenda E Jones
Journal:  Lung       Date:  2014-10-16       Impact factor: 2.584

Review 5.  Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Authors:  Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 6.  Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.

Authors:  Hebah Alhajeri; Fatemah Abutiban; Wasl Al-Adsani; Adel Al-Awadhi; Ali Aldei; Ahmad AlEnizi; Naser Alhadhood; Adeeba Al-Herz; Waleed Alkandari; Ahmad Dehrab; Aqeel A Muhanna Ghanem; Eman Hasan; Sawsan Hayat; Khulood Saleh; Hoda Tarakmeh; Yaser Ali
Journal:  Rheumatol Int       Date:  2019-07-15       Impact factor: 2.631

7.  Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists.

Authors:  I Sauzullo; R Scrivo; F Mengoni; A Ermocida; M Coppola; G Valesini; V Vullo; C M Mastroianni
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 8.  Central Nervous System Infections Associated with Immunosuppressive Therapy for Rheumatic Disease.

Authors:  Michael J Bradshaw; Tracey A Cho; Felicia C Chow
Journal:  Rheum Dis Clin North Am       Date:  2017-08-23       Impact factor: 2.670

Review 9.  Challenging issues in tuberculosis in solid organ transplantation.

Authors:  David J Horne; Masahiro Narita; Christopher L Spitters; Soumya Parimi; Sherry Dodson; Ajit P Limaye
Journal:  Clin Infect Dis       Date:  2013-07-29       Impact factor: 9.079

10.  [Prophylaxis and treatment of infections in elderly patients with rheumatism].

Authors:  C Kneitz; A Strangfeld; K Krüger
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.